Annual Operating Expenses
$206.06 M
+$59.16 M+40.27%
31 December 2023
Summary:
Day One Biopharmaceuticals annual total operating expenses is currently $206.06 million, with the most recent change of +$59.16 million (+40.27%) on 31 December 2023. During the last 3 years, it has risen by +$192.28 million (+1395.17%). DAWN annual operating expenses is now at all-time high.DAWN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$62.53 M
-$59.76 M-48.86%
30 September 2024
Summary:
Day One Biopharmaceuticals quarterly total operating expenses is currently $62.53 million, with the most recent change of -$59.76 million (-48.86%) on 30 September 2024. Over the past year, it has increased by +$11.10 million (+21.57%). DAWN quarterly operating expenses is now -63.47% below its all-time high of $171.19 million, reached on 01 September 2019.DAWN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DAWN Operating Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +40.3% | +21.6% |
3 y3 years | +1395.2% | +225.0% |
5 y5 years | - | -62.8% |
DAWN Operating Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +1395.2% | -48.9% | +225.0% |
5 y | 5 years | at high | +1395.2% | -63.5% | +3435.1% |
alltime | all time | at high | +1395.2% | -63.5% | +3435.1% |
Day One Biopharmaceuticals Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $62.53 M(-48.9%) |
June 2024 | - | $122.29 M(+83.2%) |
Mar 2024 | - | $66.77 M(+12.2%) |
Dec 2023 | $206.06 M(+40.3%) | $59.52 M(+15.7%) |
Sept 2023 | - | $51.44 M(+4.4%) |
June 2023 | - | $49.25 M(+7.4%) |
Mar 2023 | - | $45.85 M(+7.3%) |
Dec 2022 | $146.91 M(+102.0%) | $42.74 M(+7.7%) |
Sept 2022 | - | $39.70 M(+8.1%) |
June 2022 | - | $36.72 M(+32.3%) |
Mar 2022 | - | $27.75 M(+26.3%) |
Dec 2021 | $72.74 M | $21.98 M(+14.2%) |
Sept 2021 | - | $19.24 M(+24.6%) |
Date | Annual | Quarterly |
---|---|---|
June 2021 | - | $15.44 M(-4.0%) |
Mar 2021 | - | $16.09 M(+161.8%) |
Dec 2020 | $13.78 M(-7.5%) | $6.14 M(+72.5%) |
Sept 2020 | - | $3.56 M(+54.2%) |
June 2020 | - | $2.31 M(+30.5%) |
Mar 2020 | - | $1.77 M(-98.9%) |
Dec 2019 | $14.90 M | - |
Dec 2019 | - | $168.29 M(-1.7%) |
Sept 2019 | - | $171.19 M(+4.6%) |
June 2019 | - | $163.61 M(-3.6%) |
Mar 2019 | - | $169.64 M(+7.0%) |
Dec 2018 | - | $158.54 M(+1.9%) |
Sept 2018 | - | $155.62 M(-0.4%) |
June 2018 | - | $156.25 M |
FAQ
- What is Day One Biopharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual operating expenses year-on-year change?
- What is Day One Biopharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly operating expenses year-on-year change?
What is Day One Biopharmaceuticals annual total operating expenses?
The current annual operating expenses of DAWN is $206.06 M
What is the all time high annual operating expenses for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual total operating expenses is $206.06 M
What is Day One Biopharmaceuticals annual operating expenses year-on-year change?
Over the past year, DAWN annual total operating expenses has changed by +$59.16 M (+40.27%)
What is Day One Biopharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of DAWN is $62.53 M
What is the all time high quarterly operating expenses for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly total operating expenses is $171.19 M
What is Day One Biopharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, DAWN quarterly total operating expenses has changed by +$11.10 M (+21.57%)